CARTEOLOL vs CASIRIVIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CARTEOLOL vs CASIRIVIMAB: Safety Overview
| Metric | CARTEOLOL | CASIRIVIMAB |
|---|---|---|
| Total FAERS Reports | 318 | 500 |
| Deaths Reported | 30 | 24 |
| Death Rate | 9.4% | 4.8% |
| Hospitalizations | 93 | 209 |
| Average Patient Age | 67.5 yrs | 58.9 yrs |
| % Female Patients | 56.6% | 52.4% |
| FDA Approval Date | Dec 28, 1988 | N/A |
| Manufacturer | Sandoz Inc | N/A |
| Route | OPHTHALMIC | N/A |
| Marketing Status | Discontinued | N/A |